Loading...
•
Jun 27, 2020
Henry Schein Q2 2020 Earnings Report
Second quarter results were impacted by COVID-19, but sales improved across all business groups.
Key Takeaways
Henry Schein reported a decrease in net sales by 31.2% compared to Q2 2019, with a GAAP net loss of $11.4 million, or $0.08 per diluted share. The results reflect the impact of COVID-19, particularly in the Dental business, but sales improved as the quarter progressed due to the resumption of operations for dental and medical customers.
Q2 GAAP loss per diluted share from continuing operations was $0.08, compared to prior-year GAAP diluted EPS of $0.78.
Q2 non-GAAP diluted EPS from continuing operations was $0.00, compared to prior-year non-GAAP diluted EPS of $0.84.
Net sales for the quarter were $1.7 billion, a decrease of 31.2% compared to the second quarter of 2019.
The company is cautiously optimistic about the immediate future, focusing on cash management and monitoring global COVID-19 cases.
Henry Schein
Henry Schein
Henry Schein Revenue by Segment
Henry Schein Revenue by Geographic Location
Revenue by Segment
Global Dental Revenue
CapyFin.comGlobal Medical Revenue
CapyFin.comRevenue by Geographic Location
U.S. Distribution and Value-Added Services Revenue
CapyFin.comInternational Distribution and Value-Added Services Revenue
CapyFin.com Forward Guidance
Due to the continued uncertainty surrounding the COVID-19 pandemic and its impact to business operations, Henry Schein is not providing 2020 financial guidance at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income